"We are at a pivotal, dynamic time for our industry and company, with increased pressures rapidly evolving regulation, questions about the use and application of emerging technologies, rising medical and pharmaceutical costs, reduced government funding, decreases in the number of members we serving, and heightened consumer demands. To continue to meet our stakeholder obligations to be more innovative and affordable, we must evolve, being even more thoughtful and disciplined with our financial commitments and expenses."
What are your thoughts?